University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Vaping High vs. Low Nicotine E-Liquid

Not Applicable

Withdrawn

Conditions: Cardiovascular Risk Factor
Nicotine Dependence

Interventions: Other: Low Nicotine E-Liquid
Other: Medium or High Nicotine E-Liquid

First Posted Date: 2019-08-07

Last Posted Date: 2023-08-22

Lead Sponsor: University of California, San Francisco

Registration Number: NCT04047836

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States
🇺🇸
Zuckerberg San Francisco General Hospital, San Francisco, California, United States

Reaching Adolescent Girls and Young Women Through Girl-Friendly Drug Vendors

Not Applicable

Completed

Conditions: HIV
Contraception

Interventions: Other: AGYW-Friendly Services
Other: HIVST

First Posted Date: 2019-08-06

Last Posted Date: 2023-02-03

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 20

Registration Number: NCT04045912

Locations: 🇹🇿
Health for a Prosperous Nation, Shinyanga, Tanzania

De-escalating Vital Sign Checks

Not Applicable

Completed

Conditions: Delirium
Sleep Disturbance

Interventions: Other: No EHR alert
Behavioral: Nighttime Vital Sign EHR Alert

First Posted Date: 2019-08-06

Last Posted Date: 2019-12-04

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 1436

Registration Number: NCT04046458

Locations: 🇺🇸
UCSF, San Francisco, California, United States

Encorafenib, Binimetinib, and Nivolumab in Treating Microsatellite Stable BRAF V600E Metastatic Colorectal Cancer

Phase 1

Terminated

Conditions: Metastatic Colon Adenocarcinoma
Stage IIIA Colon Cancer
Stage IIIA Rectal Cancer
Stage IIIB Colon Cancer
Stage IIIC Colon Cancer
Stage IIIC Colorectal Cancer
Stage IIIC Rectal Cancer
Stage IV Colon Cancer
Stage IIIA Colorectal Cancer
Stage IIIB Rectal Cancer

Interventions: Drug: Binimetinib
Drug: Encorafenib
Biological: Nivolumab
Other: Questionnaire Administration

First Posted Date: 2019-08-05

Last Posted Date: 2023-01-09

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 2

Registration Number: NCT04044430

Locations: 🇺🇸
Univeristy of California, San Francisco, San Francisco, California, United States
🇺🇸
Kaiser Permanente Northern California, San Francisco, California, United States

Residual Dental Pulp Tissue and Cord Blood Stem Cells

Phase 2

Withdrawn

Conditions: Irreversible Pulpitis

Interventions: Biological: Cord blood stem cells
Other: Saline solution

First Posted Date: 2019-07-31

Last Posted Date: 2020-07-27

Lead Sponsor: University of California, San Francisco

Registration Number: NCT04040127

Melatonin for Sleep in MS

Not Applicable

Completed

Conditions: Multiple Sclerosis

Interventions: Dietary Supplement: Melatonin
Dietary Supplement: Placebo

First Posted Date: 2019-07-29

Last Posted Date: 2021-01-19

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 30

Registration Number: NCT04035889

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Improving Uptake and Adherence to HIV Prevention Services With Pre-exposure Prophylaxis (PrEP), HIV Self- Testing and Adherence Support for Very High Risk HIV-negative Young Women Aged 15-24 in Kampala, Uganda

Not Applicable

Completed

Conditions: HIV/AIDS

Interventions: Behavioral: POPPi behavioral intervention

First Posted Date: 2019-07-24

Last Posted Date: 2022-03-23

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 60

Registration Number: NCT04030520

Locations: 🇺🇬
Uganda Virus Research Institute, Entebbe, Uganda

Drug-Drug Interaction Between Rifampin and Fluvastatin

Phase 4

Completed

Conditions: Drug-drug Interaction

Interventions: Drug: rifampin IV
Drug: Rifadin 300Mg Capsule
Drug: Fluvastatin 20 MG

First Posted Date: 2019-07-23

Last Posted Date: 2021-09-08

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 10

Registration Number: NCT04029584

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States

dHealth Solution for Improving Parent Adherence to Behavioral Treatment for ADHD

Not Applicable

Conditions: Attention Deficit Hyperactivity Disorder

Interventions: Device: CaregiverAssist
Behavioral: Behavioral Parent Training (CLS Parent Group)

First Posted Date: 2019-07-19

Last Posted Date: 2023-11-18

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 80

Registration Number: NCT04025814

Locations: 🇺🇸
HALP Clinic, Children's Center at Langley Porter, UCSF, San Francisco, California, United States

Weight Patterns in the Month After Birth

Completed

Conditions: Feeding; Difficult, Newborn
Feeding, Breast
Undernutrition
Stunting
Feeding Patterns
Wasting

First Posted Date: 2019-07-19

Last Posted Date: 2021-05-13

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 741

Registration Number: NCT04025827

Locations: 🇵🇰
Aga Khan University, Karachi, Pakistan
🇳🇵
Dhulikhel Hospital, Dhulikhel, Nepal
🇺🇸
University of California, San Francisco, San Francisco, California, United States

and more 2 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy